Free Trial
ASX:FPH

Fisher & Paykel Healthcare (FPH) Stock Price, News & Analysis

Fisher & Paykel Healthcare logo

About Fisher & Paykel Healthcare Stock (ASX:FPH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
575,466 shs
Average Volume
N/A
Market Capitalization
$20.55 billion
P/E Ratio
157.79
Dividend Yield
1.14%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Receive FPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

FPH Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Elon Musk has done it again. He’s developed a powerful new AI model that’s already turning heads — and turning the industry upside down. Some say it could threaten Google’s search engine dominance. Others believe it could mark the beginning of the end for ChatGPT.
See More Headlines

FPH Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Fisher & Paykel Healthcare investors own include ResMed (RMD), CSL (CSL), Mineral Resources (MIN), NVIDIA (NVDA), Accent Group (AX1), Cochlear (COH) and Corporate Travel Management (CTD).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Real Estate
Current Symbol
ASX:FPH
CIK
N/A
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

Trailing P/E Ratio
157.79
Forward P/E Ratio
N/A
P/E Growth
4.47
Net Income
$132.60 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.74 billion
Price / Cash Flow
99.62
Book Value
A$2.95 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$20.55 billion
Optionable
Not Optionable
Beta
0.42
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ASX:FPH) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners